RNA-based therapeutics are transforming medicine, but scaling production efficiently remains a challenge, particularly the cost-intensive in vitro transcription (IVT) step. Join this webinar to ...

In recent years, fed-batch biomanufacturing has begun giving way to continuous manufacturing processes, as developers face pressure to balance affordability with high manufacturing quality. Although ...

New perfusion technologies and AI-driven controls are accelerating adoption across commercial biologics manufacturing.

Process analytical technology enables data-driven scale-up by embedding real-time analytics from development through ...